Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 300 participants.
Also called NCT07308847
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Registry
-
NCT07308847
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07308847. Allocation not applicable; no masking; primary purpose treatment. Start 2026-01-15 (actual); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
- Acronym
- Horizon 360
- Condition
- Paroxysmal AF
- Intervention (Device)
- Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation System
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct07308847- Content hash
73fec65211b1b228e64762c668722100b41eb837ae96a3bf9e2568e798c8cb15